Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues:    
Revenues and management fees from company clinics $ 2,515,601 $ 1,658,553
Royalty fees 1,706,073 1,368,831
Franchise fees 449,500 514,800
Advertising fund revenue 598,436 265,721
IT related income and software fees 267,013 221,134
Regional developer fees 76,896 147,537
Other revenues 60,338 88,460
Total revenues 5,673,857 4,265,036
Cost of revenues:    
Franchise cost of revenues 683,243 694,735
IT cost of revenues 58,861 45,228
Total cost of revenues 742,104 739,963
Selling and marketing expenses 958,706 738,683
Depreciation and amortization 577,987 575,544
General and administrative expenses 4,564,079 5,692,056
Total selling, general and administrative expenses 6,100,772 7,006,283
Loss on disposition or impairment 417,971
Loss from operations (1,586,990) (3,481,210)
Other (expense) income, net (19,465) 473
Loss before income tax expense (1,606,455) (3,480,737)
Income tax expense (40,609) (44,397)
Net loss and comprehensive loss $ (1,647,064) $ (3,525,134)
Loss per share:    
Basic and diluted loss per share (in dollars per share) $ (0.13) $ (0.28)
Basic and diluted weighted average shares (in shares) 13,042,595 12,567,901